These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1923170)

  • 21. Prolactin secretion and corpus luteum function in women with luteal phase deficiency.
    Soules MR; Bremner WJ; Steiner RA; Clifton DK
    J Clin Endocrinol Metab; 1991 May; 72(5):986-92. PubMed ID: 2022718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of gonadotropins, prolactin, and progesterone in infertile female Africans.
    Kuku SF; Akinyanju PA; Ojeifo JO
    Int J Fertil; 1987; 32(5):393-8. PubMed ID: 2889688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study].
    Milewicz A; Gejdel E; Sworen H; Sienkiewicz K; Jedrzejak J; Teucher T; Schmitz H
    Arzneimittelforschung; 1993 Jul; 43(7):752-6. PubMed ID: 8369008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
    Parra A; Crespo G; Coria I; Espinosa de los Monteros A
    Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular phase treatment of luteal phase defect with follicle-stimulating hormone in infertile women.
    Huang KE; Muechler EK; Bonfiglio TA
    Obstet Gynecol; 1984 Jul; 64(1):32-6. PubMed ID: 6429590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of bromocriptine treatment on prolactin secretion in infertile women with suspicion of luteal phase insufficiency].
    Krzemiński A; Sikorski R; Woźniak S
    Ginekol Pol; 1998 Dec; 69(12):1141-5. PubMed ID: 10224791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of luteal phase inadequacy with bromocriptine.
    Saunders DM; Hunter JC; Haase HR; Wilson GR
    Obstet Gynecol; 1979 Mar; 53(3):287-9. PubMed ID: 424098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clomiphene citrate therapy of infertile women with low luteal phase progesterone levels.
    Hammond MG; Talbert LM
    Obstet Gynecol; 1982 Mar; 59(3):275-9. PubMed ID: 7078874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of prolactin and bromocriptine on the luteal phase in infertile women.
    Fredricsson B; Carlström K; Björk G; Messinis I
    Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):319-33. PubMed ID: 6785120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with bromocriptine for the treatment of female infertility due to hyperprolactinemia.
    Lin SQ; Gu CX; Xu L; Wang HL; Ge QS
    Chin Med J (Engl); 1991 Aug; 104(8):679-84. PubMed ID: 1914636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial dating correlated with multiple luteal progesterone levels in confirming ovulation and luteal function in infertile Nigerian women.
    Ilesanmi AO
    West Afr J Med; 1995; 14(3):152-6. PubMed ID: 8519702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy.
    Giusti M; Fazzuoli L; Cavallero D; Valenti S
    Gynecol Endocrinol; 2002 Oct; 16(5):407-12. PubMed ID: 12587536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
    Kano T; Nishikawa K
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experiences with bromocriptine treatment of female infertility due to hyperprolactinemia].
    Lin SQ
    Zhonghua Fu Chan Ke Za Zhi; 1992 Jan; 27(1):28-31, 59. PubMed ID: 1505275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of borderline hyperprolactinemia.
    del Pozo E
    Horm Res; 1985; 22(3):204-8. PubMed ID: 4054840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The origin of hyperprolactinemia associated with infertility and its treatment with Bromocriptin-Richter tablets].
    Farkas M; Tárczy C; Tóth E
    Acta Pharm Hung; 1991 Sep; 61(5):262-76. PubMed ID: 1785356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hyperprolactinemic luteal insufficiency with bromocriptine.
    Andersen AN; Larsen JF; Eskildsen PC; Knoth M; Micic S; Svenstrup B; Nielsen J
    Acta Obstet Gynecol Scand; 1979; 58(4):379-83. PubMed ID: 525272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of the metoclopramide test in diagnosis of hormonal causes of female sterility].
    Matt O; Gerhard I; Runnebaum B
    Zentralbl Gynakol; 1992; 114(11):539-46. PubMed ID: 1481585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of transient or occult hyperprolactinemia on luteal function].
    Aisaka K; Ando S; Kokubo K; Yoshida K; Mori H
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):117-25. PubMed ID: 3084307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.